INDEGENE
|
The Current P/B Ratio of INDEGENE is 5.17.
Share Price | ₹555.3 | Jul 25,2025 |
Market Cap | ₹13,332.8 Cr | |
Book Value | ₹2,579.5 Cr | Mar2025 - Consolidated Results |
Price/Book | 5.17x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of INDEGENE
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹13,332.8 Cr] as on Jul 25,2025
(/) Book Value [ ₹2,579.5 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 5.17x ]
Thus, for INDEGENE , the investors are currently willing to pay '5.17 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of INDEGENE !
The chart below summarizes the trend in P/B Ratio of INDEGENE over the last five years.
Historical PB (Price/Book ) ratio chart of INDEGENE
PB Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.07x.
- INDEGENE 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/b ratio peaked in Mar2025 at 5.37x.
- INDEGENE 's p/b ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
INDEGENE | 2,579.50 | 5.17 | 13,332.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.64 | 407,551.0 |
DIVIS LABORATORIES LTD | 14,969.00 | 11.74 | 175,704.0 |
CIPLA LTD | 31,079.30 | 3.98 | 123,675.0 |
TORRENT PHARMACEUTICALS LTD | 7,590.69 | 16.06 | 121,925.0 |
DR REDDYS LABORATORIES LTD | 33,404.90 | 3.19 | 106,626.0 |
MANKIND PHARMA LTD | 14,288.70 | 7.51 | 107,363.0 |
ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.10 | 98,278.9 |
LUPIN LTD | 17,119.50 | 5.21 | 89,109.1 |
AUROBINDO PHARMA LTD | 32,653.30 | 2.00 | 65,180.5 |
ABBOTT INDIA LTD | 4,204.27 | 17.07 | 71,761.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs INDEGENE 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.00x |
Max industry PB | 17.07x |
Median industry PB | 5.21x |
Average industry PB | 7.42x |
You may also like the below Video Courses